175 related articles for article (PubMed ID: 34623932)
1. One single-center serological survey on measles, rubella and mumps antibody levels of people in Youyang, China.
Wang Q; Cheng X; Liu D; Chen C; Yao K
Hum Vaccin Immunother; 2021 Nov; 17(11):4203-4209. PubMed ID: 34623932
[TBL] [Abstract][Full Text] [Related]
2. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
Gupta M; Tripathy JP; Verma M; Singh MP; Kaur R; Ratho RK; Kumar R
Indian J Med Res; 2019 Mar; 149(3):396-403. PubMed ID: 31249206
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
[TBL] [Abstract][Full Text] [Related]
5. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
Mossong J; Putz L; Schneider F
Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
Amela C; Pachón I; de Ory F
Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.
Plans P; de Ory F; Campins M; Álvarez E; Payà T; Guisasola E; Compte C; Vellbé K; Sánchez C; Lozano MJ; Aran I; Bonmatí A; Carreras R; Jané M; Cabero L
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1161-71. PubMed ID: 25666082
[TBL] [Abstract][Full Text] [Related]
9. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
[TBL] [Abstract][Full Text] [Related]
10. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
[TBL] [Abstract][Full Text] [Related]
11. Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease.
Bernstein CN; Rawsthorne P; Blanchard JF
Inflamm Bowel Dis; 2007 Jun; 13(6):759-62. PubMed ID: 17230540
[TBL] [Abstract][Full Text] [Related]
12. Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.
Nogareda F; Gunregjav N; Sarankhuu A; Munkhbat E; Ichinnorov E; Nymadawa P; Wannemuehler K; Mulders MN; Hagan J; Patel MK
Vaccine; 2020 May; 38(26):4200-4208. PubMed ID: 32381479
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
[TBL] [Abstract][Full Text] [Related]
14. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
[TBL] [Abstract][Full Text] [Related]
15. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
[TBL] [Abstract][Full Text] [Related]
16. Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: A 4-year prospective study.
Liu Y; Xiong Y; Liang Y; Deng X; Hu Y; Hu R; Chen Q; Tang F; Wang Z; Sun X; Guo H; Zhang L; Zhu FC
Vaccine; 2021 Jun; 39(26):3509-3515. PubMed ID: 33994238
[TBL] [Abstract][Full Text] [Related]
17. [Antibody levels of measles, rubella and mumps viruses in healthy population in Shanghai from 2010 to 2020].
Yang YY; Tang SW; Tang W; Fan JL; Li Z; Yang JW; Ren J; Li CS
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Aug; 56(8):1095-1100. PubMed ID: 35922237
[No Abstract] [Full Text] [Related]
18. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.
Béraud G; Abrams S; Beutels P; Dervaux B; Hens N
Euro Surveill; 2018 Jun; 23(25):. PubMed ID: 29945697
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life].
Devecioğlu E; Gökçay G; Boran P; Eren T; Yılmaz G; Badur S
Mikrobiyol Bul; 2018 Jul; 52(3):324-327. PubMed ID: 30156519
[TBL] [Abstract][Full Text] [Related]
20. MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland.
Johnson H; Hillary IB; McQuoid G; Gilmer BA
Vaccine; 1995 Apr; 13(6):533-7. PubMed ID: 7483773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]